Peterson Wealth Services Buys 3,292 Shares of STERIS plc $STE

Peterson Wealth Services lifted its stake in STERIS plc (NYSE:STE) by 191.0% in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 5,016 shares of the medical equipment provider’s stock after buying an additional 3,292 shares during the period. Peterson Wealth Services’ holdings in STERIS were worth $1,241,000 at the end of the most recent reporting period.

A number of other institutional investors have also added to or reduced their stakes in the company. Steigerwald Gordon & Koch Inc. acquired a new position in STERIS in the 3rd quarter valued at approximately $25,000. Spurstone Advisory Services LLC acquired a new position in shares of STERIS in the second quarter valued at $29,000. Cloud Capital Management LLC bought a new position in STERIS in the third quarter worth $29,000. Geneos Wealth Management Inc. boosted its stake in STERIS by 416.0% during the first quarter. Geneos Wealth Management Inc. now owns 129 shares of the medical equipment provider’s stock worth $29,000 after buying an additional 104 shares in the last quarter. Finally, TruNorth Capital Management LLC bought a new stake in STERIS in the 3rd quarter valued at $37,000. 94.69% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reaffirmed a “buy (b)” rating on shares of STERIS in a report on Friday, January 9th. Six analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $275.20.

STERIS Stock Performance

STERIS stock opened at $264.85 on Tuesday. The firm has a market capitalization of $25.99 billion, a P/E ratio of 38.05 and a beta of 1.03. The stock has a fifty day moving average price of $259.33 and a two-hundred day moving average price of $249.18. STERIS plc has a 52-week low of $204.90 and a 52-week high of $269.44. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.37 and a quick ratio of 1.63.

STERIS (NYSE:STE) last posted its earnings results on Wednesday, November 5th. The medical equipment provider reported $2.47 earnings per share for the quarter, topping the consensus estimate of $2.38 by $0.09. The business had revenue of $1.46 billion for the quarter, compared to analyst estimates of $1.43 billion. STERIS had a net margin of 12.07% and a return on equity of 14.43%. During the same quarter in the prior year, the firm earned $2.14 EPS. STERIS has set its FY 2026 guidance at 10.150-10.30 EPS. As a group, analysts anticipate that STERIS plc will post 9.08 EPS for the current fiscal year.

STERIS Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, March 19th. Stockholders of record on Tuesday, February 17th will be paid a $0.63 dividend. The ex-dividend date is Tuesday, February 17th. This represents a $2.52 dividend on an annualized basis and a dividend yield of 1.0%. STERIS’s payout ratio is 36.21%.

Insider Transactions at STERIS

In other STERIS news, VP John Adam Zangerle sold 15,000 shares of STERIS stock in a transaction on Tuesday, November 11th. The stock was sold at an average price of $265.14, for a total value of $3,977,100.00. Following the completion of the transaction, the vice president owned 33,669 shares in the company, valued at approximately $8,926,998.66. The trade was a 30.82% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, VP Renato Tamaro sold 5,036 shares of the stock in a transaction on Tuesday, November 18th. The stock was sold at an average price of $257.55, for a total value of $1,297,021.80. Following the sale, the vice president owned 5,695 shares in the company, valued at $1,466,747.25. The trade was a 46.93% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 25,044 shares of company stock valued at $6,586,218 in the last three months. 1.07% of the stock is owned by corporate insiders.

STERIS Profile

STERIS Corporation (NYSE: STE) is a global provider of infection prevention, contamination control and procedural products and services for the healthcare, life sciences, pharmaceutical and medical device industries. The company develops, manufactures and supports a broad portfolio of equipment and consumables designed to reduce risk of infection, maintain sterile environments and support critical clinical and manufacturing procedures.

Its offerings include sterilization and decontamination systems, instrument washers and washers-disinfectors, endoscope reprocessing solutions, surgical equipment and procedural disposables, and contamination-control products for cleanrooms and laboratories.